The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-Benzenesulfonylamino-7-pyridin-3-yl-octanoic acid hydrochloride ID: ALA557427
PubChem CID: 10001758
Max Phase: Preclinical
Molecular Formula: C19H25ClN2O4S
Molecular Weight: 376.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=C(O)CCCCCC(CNS(=O)(=O)c1ccccc1)c1cccnc1
Standard InChI: InChI=1S/C19H24N2O4S.ClH/c22-19(23)12-6-1-3-8-17(16-9-7-13-20-14-16)15-21-26(24,25)18-10-4-2-5-11-18;/h2,4-5,7,9-11,13-14,17,21H,1,3,6,8,12,15H2,(H,22,23);1H
Standard InChI Key: TUVTYRXODIEMQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 27 0 0 0 0 0 0 0 0999 V2000
6.3877 4.5062 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5857 6.0115 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2886 5.2566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5897 4.8115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6268 5.4148 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5814 7.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9142 9.7501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2928 3.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9541 10.3489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0044 3.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8758 10.3516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9115 8.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2802 8.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8783 8.2661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3050 3.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6109 7.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3076 5.2506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6082 5.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2759 9.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8740 9.7660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5728 10.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
2 5 2 0
2 6 1 0
3 9 1 0
7 10 2 0
9 12 1 0
11 12 1 0
7 13 1 0
8 14 1 0
11 14 2 0
7 15 1 0
8 16 2 0
6 17 1 0
6 18 2 0
11 19 1 0
12 20 1 0
15 21 1 0
20 22 1 0
21 23 1 0
22 23 1 0
16 24 1 0
19 24 2 0
17 25 2 0
18 26 1 0
25 27 1 0
26 27 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.48Molecular Weight (Monoisotopic): 376.1457AlogP: 3.18#Rotatable Bonds: 11Polar Surface Area: 96.36Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.00CX Basic pKa: 4.96CX LogP: 1.99CX LogD: -0.16Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.59Np Likeness Score: -0.60
References 1. Main AJ, Goldstein R, Cohen DS, Furness P, Lee W.. (1992) Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds., 35 (23): [PMID:1447736 ] [10.1021/jm00101a013 ] 2. Main AJ, Goldstein R, Cohen DS, Furness P, Lee W.. (1992) Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds., 35 (23): [PMID:1447736 ] [10.1021/jm00101a013 ]